Yunkang Group Limited (SEHK: 2325)
Health Care · Health Care Providers & Services · CN
HK$0.65
+1.56% today · -75.7% 1Y
Yunkang Group Limited (SEHK: 2325) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $48.48M and employs 1,064 people.
Over the last twelve months the share price has lost 75.7%, trading between 0.55 and 3.07.
Tweenvest scores Yunkang Group Limited across four factors: quality 70/100, value 55/100, growth 26/100. Its strongest factor is quality.
2325 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $48.48M
- Revenue (TTM)
- $85.98M
- P/E
- 117.10
- EPS
- 0.00
- Dividend yield
- —
- Beta (5Y)
- -0.80
- 52-week high
- HK$3.07
- 52-week low
- HK$0.55
- Avg volume (3M)
- —
- Shares outstanding
- 585.34M
- Employees
- 1,064
- Next earnings
- —
About Yunkang Group Limited
Yunkang Group Limited, established in 2008 and headquartered in Guangzhou, People's Republic of China, operates as a comprehensive provider of medical operational services. The company offers a wide range of diagnostic testing solutions to medical institution alliances, which encompass assisting with the setup and enhancement of diagnostic centers, developing standard operating procedures for testing, delivering expert diagnostic consultations and staff training, sourcing necessary equipment, implementing smart Internet of Things technology, and providing logistics support. For diagnostic outsourcing, Yunkang Group conducts diverse tests, including pathology examinations; infectious disease diagnostics for conditions such as hepatitis B, tuberculosis, human papillomavirus, Epstein-Barr virus, rabies, and respiratory pathogens (via nucleic acid testing); genetic and reproductive health screenings; and routine diagnostic assessments for chronic ailments like kidney, blood, autoimmune, and endocrine metabolic diseases. Furthermore, the company caters to financial institutions and insurance firms by offering personalized diagnostic testing, medical report interpretation, and hospital referral services. Yunkang Group's capabilities also extend to information technology, medical logistics, procurement of medical equipment, healthcare technology development, and various project investments. These services are delivered through its network of independent clinical laboratories and integrated on-site diagnostic facilities.
- ISIN
- KYG9889T1067
- Founded
- 2008
- Listed since
- May 18, 2022
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $359.94B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $120.63B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $104.54B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.48B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $87.30B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $74.22B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.55B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.45B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.